Skip to main content
  • Research article
  • Open access
  • Published:

HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review



Despite global efforts to control HIV among key populations, new infections among men who have sex with men (MSM) and transgender (TG) individuals are still increasing. The increasing HIV epidemic among MSM/TG in China indicates that more effective services are urgently needed. However, policymakers and program managers must have a clear understanding of MSM/TG sexual health in China to improve service delivery. To meet this need, we undertook a scoping review to summarize HIV epidemiology and responses among MSM and TG individuals in China.


We searched MEDLINE, EMBASE and the Cochrane Library for recent studies on MSM/TG HIV epidemiology and responses. We also included supplemental articles, grey literature, government reports, policy documents, and best practice guidelines.


Overall, HIV prevalence among Chinese MSM was approximately 8 % in 2015 with a higher prevalence observed in Southwest China. TG are not captured in national HIV, STD, or other sexual health surveillance systems. There is limited data sharing between the public health authorities and community-based organizations (CBOs). Like other low and middle income countries, China is challenged by low rates of HIV testing, linkage, and retention. Several pilot interventions have been shown to be effective to increase HIV testing among MSM and TG individuals, but have not been widely scaled up. Data from two randomized controlled trials suggests that crowdsourcing contests can increase HIV testing, creating demand for services while engaging communities.


Improving HIV surveillance and expanding HIV interventions for Chinese MSM and TG individuals are essential. Further implementation research is needed to ensure high-quality HIV services for MSM and TG individuals in China.

Peer Review reports


In 2015 the WHO launched a comprehensive revision of the 2013 consolidated ARV guidelines, recommending immediate treatment for all people living with HIV and pre-exposure prophylaxis (PrEP) for people at high risk of HIV infection [1, 2]. At the same time, UNAIDS declared that the world should end the AIDS epidemic by 2030, with the goal of achieving the 90-90-90 diagnosis and treatment targets by 2020 [3]. Given these goals, it is imperative that we have a better understanding of key populations, including men who have sex with men (MSM) and transgender individuals (TG).

Globally, MSM are 19 times more likely to be living with HIV than the general population [4]. Despite global efforts to control HIV among key populations, new infections among MSM are still increasing [57]. High HIV prevalence was consistently observed among MSM in many regions around the world. For example in 2012, the HIV prevalence among MSM in the Caribbean was as high as 25 % [8]. Similar patterns have also been observed in Asia [8]. TG individuals are also an important, but often neglected, key population [9, 10].

The Chinese government has increased policy attention to HIV in recent years, providing an opportunity to enhance service delivery for MSM and TG individuals [11]. The purpose of this scoping review was to summarize HIV epidemiology and responses among MSM and TG individuals in China.


We undertook a scoping review to summarize the MSM/TG HIV epidemics in China, sexual health services across the HIV care continuum, and interventions for Chinese MSM/TG. In addition, based on the literature review, we summarized several policy points for consideration.

We used Arksey and O’Malley’s framework for conducting this scoping study. Scoping studies summarize key evidence on a topic, but do not go through the process of a formal systematic review [12]. We identified studies published between January 2009 and October 2015 that reported on Chinese MSM HIV epidemiology, sexual health services across the HIV care continuum, and sexual health interventions. Studies were identified using keyword searches in electronic databases. We searched the following databases: MEDLINE (OVID interface, 1946 onwards), EMBASE (OVID interface, 1947 onwards) and the Cochrane Library. The search string used synonyms and variations of the following terms: MSM, TG, meta-analysis, review and China.

We included studies that had the following elements: 1) Study designs were systematic reviews; 2) Study participants were MSM or TG in China; and 3) Outcomes included data on health services across the HIV care continuum or interventions targeting Chinese MSM or TG. If data of interest were not available in systematic reviews, supplemental articles, grey literature, government reports, policy documents, and best practice guidelines were also included. We also contacted experts at the Chinese CDC, WHO, Gates Foundation and UNAIDS to provide reports, policy documents, and guidelines. Our preliminary report was reviewed by civil society organizations, UN organizations, the WHO China office, and two external reviewers.


HIV epidemiology and surveillance

Population size estimation and data sharing

The WHO estimated 2–10 million MSM in China in 2009 [13]. China reported that about 2–4 % adult male population in urban areas and 1–2 % adult male population in rural areas are MSM, and estimated that the number of MSM in China may range from 3.1 to 6.3 million in 2009 [14]. Another study in China estimated that there were 5–10 million MSM in China [15].

Collected data is shared among some public health organizations and community-based organizations (CBOs). However, most of the MSM CBOs that work closely with local CDC have limited access to MSM health surveillance and related data [1618].

HIV prevalence among Chinese MSM

The HIV prevalence was estimated to be 6.0 % in 2010 [16], and it has gradually increased to 8.0 % in 2015 (Fig. 1) [19]. Regional disparity is an important feature of the HIV epidemic among Chinese MSM. Based on a systematic review, HIV prevalence is increasing across all regions of China, particularly in the southwest region, made up of five provinces [16]. The average HIV prevalence in this region was three times the overall Chinese average. In addition, municipalities and provincial capitals also have higher HIV prevalence, compared to other cities [20].

Fig. 1
figure 1

HIV prevalence among Chinese MSM based on Chinese surveillance system. Source: Chinese CDC [19] and AIDSInfo (

Young MSM worldwide and in Asia have increased risks of acquiring HIV and STDs [21]. In China, a study conducted across four cities reported an HIV prevalence of 6.7 % among MSM between 16 and 24 years old [22].

Routine HIV surveillance in China does not capture TG individuals and most of the studies reviewed did not mention TG individuals. One study found that 11.1 % of transgender individuals self-reported HIV infection [23] and another found a high burden of intimate partner violence and risky sexual behaviors [24].

Condom use and drug use among Chinese MSM

The results from six reviews [2530] that summarized condom usage among Chinese MSM reveal that though large efforts (e.g., condom promotion in venues, peer education, and condom promotion through social media) have been made towards containing HIV, the overall rate of condomless anal intercourse (CAI) is still high. According to one meta-analysis that included 64 articles reported 82 studies [28], the CAI (during last 6 months) rate among Chinese MSM is about 54 % (95 % CI: 51–56 %). Data from the Chinese surveillance system showed that about 51 % of MSM reported engaging in CAI in the last 6 months in 2013 [19]. In addition to CAI with men, many Chinese MSM also have condomless sex with women. One meta-analysis that included 43 studies reported that the pooled estimates condomless sex rate with female sex partners was 74 % (95 % CI: 72–77 %) in the last 6 months [31].

A systematic review of 33 studies reported that the drug use rate ranged between 0.1 and 44 % among Chinese MSM (median = 2.4 %) [27]. In China, recreational drug use has increased considerably among MSM in recent years [30]. A multisite cross-sectional study reported that 28 % of MSM had used at least one kind of recreational drug in the last 6 months [32]. Among MSM, the most prevalent stimulant drugs were ecstasy and crystal meth. Popular non-stimulant drugs include Viagra and Ketamine [33].

HIV care continuum

Since 2008, the China MOH carried out comprehensive AIDS responses with MSM populations in 61 cities across China, including expanding MSM surveillance, increasing HIV testing, case finding, and promoting linkage to care [20]. These policies helped to define and strengthen the HIV care continuum for MSM. Programs for HIV testing, linkage to care, adherence, and retention have all expanded in the past 5 years.

HIV testing

Data from national HIV surveillance system illustrated that the HIV testing rate (tested in last year) among Chinese MSM ranged between 43.2 and 49.0 % [19]. In addition, results from a meta-analysis of 18 studies suggested that only 47 % of Chinese MSM had ever tested for HIV, and 38 % had tested during the past 12 months [34]. The number of surveys among young MSM indicated that HIV testing rates in this group were less than 30 % [35]. In addition, among MSM tested for HIV, several studies suggested that HIV testing is infrequent [3537]. One study noted poor HIV test uptake among TG individuals in China [23].

Several research studies have identified barriers and facilitators of HIV testing among MSM. Fear of stigma and discrimination, concerns about confidentiality, limited HIV knowledge, and institutional barriers such as inconvenient testing times were identified as barriers to accessing HIV testing [17, 3840]. Practicing high risk sexual behaviors, family and partner support, rapid testing, and self-testing were mentioned as facilitators of testing [17, 3840].

HIV linkage to care, ARV adherence and retention in care

Nationwide scale-up of HIV treatment programs has been implemented in China over the last decade. However, late diagnosis, incomplete linkage to care, and high rates of loss-to-follow-up remain major clinical and public health challenges in China [41]. Infrequent viral load monitoring and incomplete reporting within surveillance systems complicate more detailed analyses. Further strengthening of the surveillance system and implementation research are needed. A study based on the national epidemiology database reported that during 2006–2012, 21.3 % of newly diagnosed MSM did not receive CD4 cell count testing within the 6-months following diagnosis [42]. A online survey study reported consistent results (74.6 % of positive individuals saw a doctor in 6 months and 25.4 % took over 6 months to be linked to care) [43]. Multistage stepwise HIV testing and treatment initiation procedures are major structural barriers to providing timely antiretroviral therapy [41].

A study conducted in 2014 indicated that many HIV-infected individuals are receiving ART that is sub-optimal, even after they receive definite diagnosed [44]. Among MSM patients with CD4 cell count ≤ 350 cells//mm3, only around 60 % received ART [44, 45]. A study conducted in Guangzhou reported that among 721 adults living with HIV receiving ART, 18.9 % reported recent non-adherence (any missed ART in the past 4 weeks) and 6.8 % reported treatment interruption (4 or more weeks of missed ART in the past year) [46].

Retention in care among MSM patients is also not optimal [41, 42, 44]. Based on a study conducted during 2003 to 2009, people living with HIV receiving ART reported that the median length of time on ART was 18.9 months, and the cumulative probability of attrition from ART initiation was 9 % at 12 months and 24 % at 60 months. This nationwide study showed that MSM retention rates were better than other risk groups. A retrospective cohort study conducted in Changsha reported a retention rate of 58.1 % at 12 months, with no difference in retention reported between MSM and others [47].

These studies also showed that MSM face a number of individual and structural barriers across the HIV care continuum. Negative coping methods create significant problems for linking newly-diagnosed men to care and retaining them in care. Meanwhile, qualitative research indicates that nondisclosure of sexual orientation to families, absence peer social support and professional psychological counseling, lack of affordable and specialized treatment and care, homophobia and discrimination from providers may deter engagement in care [40, 48].

Interventions ongoing and completed

Prevention and behavioral interventions at individual and group-level

Since 2005, the Chinese government has expanded its intervention efforts to MSM [49]. Various programs have been conducted to promote condom use, counseling and testing, peer education, and follow-up outreach. A meta-analysis that summarized 22 MSM intervention studies suggested that behavioral interventions have been efficacious in increasing HIV knowledge, HIV testing, and condom use, and in reducing sexual risk behaviors. However, the study also indicated that interventions have not reduced the incidence of HIV among Chinese MSM [50].

Interventions for promoting HIV Self-testing (HIVST) in China

HIVST is not illegal in China, and more than 20 HIVST kits have been approved by the Chinese Food and Drug Administration [51] and are available in China [52]. There is currently no national program of HIVST among MSM in China, however around one quarter of Chinese MSM have self-tested for HIV [52, 53]. Several pilot programs have shown that HIVST is an additional HIV testing method that could increase first-time HIV testing [53, 54]. Many pilot interventions have been conducted to examine the efficacy of hybrid CBO-clinic models in promoting HIV testing and linkage to care (Table 1). These interventions primarily focus on improving cooperation among CDC system, hospital and MSM CBOs in China [46, 55]. For example, by collaborating with a local CBO, the Guangzhou CDC built a social entrepreneurship model to promote HIVST among MSM [56]. Overall, 198 (52.1 %) MSM purchased self-testing kits, and 192 (97.0 %) participants used kits and returned the testing results [57].

Table 1 Project IMPACT: A Model for Increasing the Collaboration between Community-based Organizations and the Public Sector in China

Internet-based and social media interventions

A few internet-based interventions have been conducted to improve accessibility to HIV services and care [55, 58, 59]. For example, the Guangzhou CDC developed two internet-based interventions: ‘scenario experiencing intervention application’ and ‘online HIV risk self-assessment system’ [58]. Compared to the control group, participants in the intervention arm of HIV risk-assessment system had reduced CAI in the last anal sex by 44 %, and CAI with regular and casual partners within the last three months by 26 and 25 % respectively [58].

Various social media techniques have been applied to HIV educational interventions as well as to testing mobilization and partner services interventions targeted towards MSM in China. Danlan Gongyi, an LGBT online web portal and CBO, used Wechat to provide rapid and anonymous HIV testing services as well as offline services such as psychological counseling and support [3]. Other social media platforms, such as QQ, Jack’d and microblogging, have been also used in carrying out HIV/AIDS interventions among Chinese MSM [60, 61].

Crowdsourcing HIV test promotion interventions

Crowdsourcing is “the practice of obtaining needed services, ideas, or content by soliciting contributions from a large group of people and especially from the online community [62].” Crowdsourcing can be used to solicit concepts, images, and videos to promote HIV testing (Table 2). Several crowdsourcing contests have been implemented in South China. One randomized controlled trial (RCT) in China aimed at promoting HIV testing showed that crowdsourcing methods were both effective and cost saving when compared to a health marketing intervention. HIV test uptake was similar between the crowdsourced arm (37 %, 114/307) and the health marketing arm (35 %, 111/317) [52]. Another RCT in China found that a crowdsourced intervention was non-equivalent to a social marketing intervention, also noting cost savings [63].

Table 2 SESH and crowdsourcing contests to create demand for HIV testing and other services

Interventions for improving linkage and retention in care

In 2012, the China CDC initiated a pilot intervention project to demonstrate a ‘one-stop’ service model for individuals with HIV infection [44]. This model included referral, transportation, information and emotional support. Patients in the service clinic receive all procedures and protocols in a single setting. The pilot intervention demonstrated that this model outperformed the existing service model on five out of six indicators. Between 2012 and 2014, the Chinese CDC in Guangxi also piloted a program for immediate initiation of ART [41]. The intervention significantly increased ART coverage within 90 days of diagnosis of HIV infection, and reduced overall mortality from about 26 % to less than 10 % [41].

Pre-exposure prophylaxis (PrEP)

The use of PrEP is now recommended by the WHO for all individuals at substantial risk of acquiring HIV [64]. China has yet to make new recommendations with regard to PrEP. Few studies suggest that while awareness remains low (ranging from 2.8 to 22 %), willingness to use PrEP is high (ranging from 64.0 to 84.6 %) [6568].

Two PrEP demonstration projects in China have been published to date [69, 70]. The first one compared the effect of combination regimen of TDF + FTC daily to TDF + FTC taken twice weekly plus an additional dose 2 h before sex. Among 153 MSM, 79.7 % completed 28 weeks of follow up, and 68.6 % reported not missing a dose [69]. The second study allowed participants to choose the no drug intervention, daily TDF or peri-coital dosing (1 dose TDF 24–48 h before sex plus 1 dose TDF within 2 h after sex). Retention at 12 months was relatively low (43.1 %), and varied significantly across study arms [70].


Based on the epidemiology and response data, we identified a number of opportunities to strengthen the HIV response and decrease HIV risk among MSM in China. These opportunites include improving HIV surveillance and expanding interventions among MSM and transgender individuals.

Improving HIV surveillance

Given the size and complexity of China, an accurate MSM/TG HIV surveillance system is critical. Two areas could improve HIV surveillance among these key populations: 1) enhancing data sharing between CBOs and CDCs; 2) using online surveys to capture MSM and TG individuals. Several interventions suggest the importance of collaborative CBO-CDC programs across the continuum of care. However, MSM CBOs often have limited access to MSM sexual health surveillance data. Increased data sharing between CBOs and local CDCs could improve service provision, needs assessment, and intervention development.

Online surveys can also help capture real-time HIV surveillance data. Large numbers of MSM in China routinely use the Internet [20], especially smart-phone based partner-seeking mobile applications [49]. Some online MSM are difficult to reach through the current MSM surveillance system [23]. Integrating online data collection into the surveillance system could make it easier to reach some subgroups of MSM. Currently, there is very limited data specific on TG individuals. Conducting online surveillance among online TG individuals could be useful, as previous studies have shown that online sampling can reduce some of the social and structural barriers that limit efforts to reach TG [23, 24]. Data security and confidentiality are important concerns in the context of using online surveys.

Expanding HIV interventions for MSM and TG individuals

Our review identified a number of MSM/TG interventions that could be expanded, including the following: 1) HIVST interventions to expand HIV testing; 2) crowdsourcing and social media interventions to stimulate demand for HIV services; 3) community-based interventions.

HIVST may be a useful tool for expanding HIV testing and promoting people-centered systems. Although HIVST systems tailored for MSM have been piloted in many Chinese cities [53, 57, 58], none have been widely scaled up. Expanding the use of HIVST among MSM represents a major opportunity for public health systems to reach MSM and TG individuals with suboptimal HIV test uptake. The expansion of HIVST may require new organizations such as a social enterprise [71] which combine elements of enterprise and social welfare organization.

Both crowdsourcing and social media interventions have proven effective in stimulating demand for HIV services in China. Two randomized controlled trial studies demonstrated that a crowdsourcing approach was effective and cost saving method among MSM and TG individuals in China [52, 63]. This method could increase community engagement in HIV campaigns [52]. A crowdsourcing approach could also be used to increase demand for PrEP and partner services. In addition to crowdsourcing, other types of social media interventions may help to increase HIV service demand [72, 73].

Community-based interventions are an important part of the HIV response among MSM and TG individuals. Supporting local community-based organizations to implement community-based interventions should be considered. At a national and sub-national level, the participation of key populations and key populations living with HIV must be considered in formulating strategies and programming [58]. Within the many CDC-CBO hybrid models, ensuring governance and resources to support community voices is important.


Implementation of HIV interventions, especially those focused on serving MSM and TG individuals, is an enormous challenge [74]. Implementation science research can help identify and anticipate problems, and in turn, answer questions on how best to deliver interventions [75]. Incomplete surveillance and reporting systems, especially for TG individuals, underlines the need for strengthened routine surveillance and further research. This scoping review suggests several unmet implementation needs for MSM and TG in China.



Antiretroviral therapy




Condomless anal intercourse


Community based organization(s)


Centers for disease control and prevention


HIV self-testing


HIV testing service


Implementation science research


Key population(s)


Lesbian, gay, bisexual and transgender


Men who have sex with men


People living with HIV


Pre-exposure prophylaxis


Partner services


Ribonucleic acid


Sexually transmitted diseases(s)


Sexually transmitted infection(s)


Joint United Nations Programme on HIV/AIDS


Voluntary counselling and testing


Viral load


World Health Organization


  1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013.

    Google Scholar 

  2. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.

    Google Scholar 

  3. UNAIDS: World AIDS Day Report: Focus on location and population. In. New York; 2015

  4. UNAIDS. The Gap report, vol. 2014. New York: UNAIDS; 2014. Accessed 7 Oct 2016.

  5. van Griensven F, van Wijngaarden JWL. A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. AIDS. 2010;24:S30–40.

    Article  PubMed  Google Scholar 

  6. van Griensven F, van Wijngaarden JWL, Baral S, Grulich A. The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS. 2009;4(4):300–7.

    Article  PubMed  Google Scholar 

  7. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, Brookmeyer R. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367–77.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz AL, Altman D, Trapence G, Mayer K. The increase in global HIV epidemics in MSM. AIDS. 2013;27(17):2665–78.

    Article  PubMed  Google Scholar 

  9. Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, Wylie K. Transgender people: health at the margins of society. Lancet. 2016;16:683–8.

    Google Scholar 

  10. Wylie K, Knudson G, Khan S, Bionerbale M, Watanyusakul W, Baral S. Serving transgender people: clinical care considerations and service delivery models in transgender health. Lancet. 2016;16:682–6.

    Google Scholar 

  11. Wu Z, Wang Y. Introduction: China meets new AIDS challenges. J Acquir Immune Defic Syndr. 2010;53:S1–3.

    Article  PubMed  Google Scholar 

  12. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.

    Article  Google Scholar 

  13. Godwin J. Legal environments, human rights and HIV responses among men who have sex with men and transgender people in Asia and the Pacific: An agenda for action. In. New York: UNDP; 2010.

    Google Scholar 

  14. Wang L, Wang N, Wang L, Li D, Jia M, Gao X, Qu S, Qin Q, Wang Y, Smith K. The 2007 estimates for people at risk for and living with HIV in China: progress and challenges. J Acquir Immune Defic Syndr. 2009;50(4):414–8.

    Article  PubMed  Google Scholar 

  15. Wong FY, Huang ZJ, Wang W, He N, Marzzurco J, Frangos S, Buchholz ME, Young D, Smith BD. STIs and HIV among men having sex with men in China: a ticking time bomb? AIDS Educ Prev. 2009;21(5):430–46.

    Article  PubMed  Google Scholar 

  16. Zhang L, Chow EP, Jing J, Zhuang X, Li X, He M, Sun H, Li X, Gorgens M, Wilson D. HIV prevalence in China: integration of surveillance data and a systematic review. Lancet Infect Dis. 2013;13(11):955–63.

    Article  PubMed  Google Scholar 

  17. Bien CH, Muessig KE, Lee R, Lo EJ, Yang LG, Yang B, Peeling RW, Tucker JD. HIV and syphilis testing preferences among men who have sex with men in South China: a qualitative analysis to inform sexual health services. PLoS One. 2015;10(4):e0124161.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tucker JD, Muessig KE, Cui R, Bien CH, Lo EJ, Lee R, Wang K, Han L, Liu FY, Yang LG, et al. Organizational characteristics of HIV/syphilis testing services for men who have sex with men in South China: a social entrepreneurship analysis and implications for creating sustainable service models. BMC Infect Dis. 2014;14:601.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Qin Q, Tang W, Ge L, Li D, Mahapatra T, Wang L, Guo W, Cui Y, Sun J: Changing trend of HIV, Syphilis and Hepatitis C among Men Who Have Sex with Men in China. Scientific Reports 2016: In Press.

  20. Wu Z, Xu J, Liu E, Mao Y, Xiao Y, Sun X, Liu Y, Jiang Y, McGoogan JM, Dou Z. HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis. 2013;57(2):298–309.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Garofalo R, Herrick A, Mustanski BS, Donenberg GR. Tip of the iceberg: Young men who have sex with men, the Internet, and HIV risk. Am J Public Health. 2007;97(6):1113–7.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wei S, Zhang H, Wang J, Song D, Duan Y, Yu F, She M, Wang M, Zhang H. HIV and syphilis prevalence and associated factors among young men who have sex with men in 4 cities in China. AIDS Behav. 2013;17(3):1151–8.

    Article  PubMed  Google Scholar 

  23. Best J, Tang W, Zhang Y, Han L, Liu F, Huang S, Yang B, Wei C, Tucker JD. Sexual Behaviors and HIV/Syphilis Testing Among Transgender Individuals in China: Implications for Expanding HIV Testing Services. Sex Transm Dis. 2015;42(5):281–5.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zhang Y, Best J, Tang W, Tso LS, Liu F, Huang S, Zheng H, Yang B, Wei C, Tucker JD: Transgender sexual health in China: a cross-sectional online survey in China. Sex Transm Infect 2016. doi: 10.1136/sextrans-2015-052350

  25. Zou H, Xue H, Wang X, Lu D. Condom use in China: prevalence, policies, issues and barriers. Sex Health. 2012;9(1):27–33.

    Article  PubMed  Google Scholar 

  26. Zhang L, Chow EP, Wilson DP. Distributions and trends in sexual behaviors and HIV incidence among men who have sex with men in China. BMC Public Health. 2012;12(1):546.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Guo Y, Li X, Stanton B. HIV-related behavioral studies of men who have sex with men in China: a systematic review and recommendations for future research. AIDS Behav. 2011;15(3):521–34.

    Article  PubMed  Google Scholar 

  28. Wu J, Hu Y, Jia Y, Su Y, Cui H, Liu H, Wang N. Prevalence of unprotected anal intercourse among men who have sex with men in China: an updated meta-analysis. PLoS One. 2014;9(5):e98366.

    Article  PubMed  PubMed Central  Google Scholar 

  29. He Q, Peng W-J, Zhang J-Q, Wang B-X, Wang J: Prevalence of unprotected anal intercourse and unprotected vaginal intercourse among HIV-positive men who have sex with men in China: a meta-analysis. Sexually transmitted infections 2011. doi: 10.1136/sextrans-2011-050230.

  30. Yang Z, Zhang S, Dong Z, Jin M, Han J. Prevalence of unprotected anal intercourse in men who have sex with men recruited online versus offline: a meta-analysis. BMC Public Health. 2014;14(1):508.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Chow EP, Wilson DP, Zhang L. What is the potential for bisexual men in China to act as a bridge of HIV transmission to the female population? Behavioural evidence from a systematic review and meta-analysis. BMC Infect Dis. 2011;11(1):242.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Xu J-J, Zhang C, Hu Q-H, Chu Z-X, Zhang J, Li Y-Z, Lu L, Wang Z, Fu J-H, Chen X. Recreational drug use and risks of HIV and sexually transmitted infections among Chinese men who have sex with men: Mediation through multiple sexual partnerships. BMC Infect Dis. 2014;14(1):642.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wei C, Guadamuz TE, Lim SH, Huang Y, Koe S. Patterns and levels of illicit drug use among men who have sex with men in Asia. Drug Alcohol Depend. 2012;120(1):246–9.

    Article  PubMed  Google Scholar 

  34. Zou H, Hu N, Xin Q, Beck J. HIV testing among men who have sex with men in China: a systematic review and meta-analysis. AIDS Behav. 2012;16(7):1717–28.

    Article  PubMed  Google Scholar 

  35. Na W, Sun Yanming LH: A Survey on HIV prevalence among Young MSM in Beijing City Chinese Journal of AIDS & STD 2013, 19(4).

  36. Qi X, Xu J, Zhang Z, Li S-m, Xiao D, Gao Y-j, Li D-l, Jiang G-y, Luo F-j, Ruan Y-h et al.: A survey on HIV and Syphilis Infections among MSM population in Beijing. Chinese Preventive Medicine 2013, 14(6).

  37. Fu J, Gong Z. An analysis of HIV prevalence and related risk behavior amongst MSM in Jiangxi Province. Jiangxi Med J. 2014;49(10):970–3.

    Google Scholar 

  38. Fan EL. HIV testing as prevention among MSM in China: the business of scaling-up. Glob Public Health. 2014;9(1–2):85–97.

    Article  PubMed  Google Scholar 

  39. Liu Y, Sun X, Qian H-Z, Yin L, Yan Z, Wang L, Jiang S, Lu H, Ruan Y, Shao Y. Qualitative Assessment of Barriers and Facilitators of Access to HIV Testing Among Men Who Have Sex with Men in China. AIDS Patient Care STDs. 2015;29(9):481–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wei C, Yan H, Yang C, Raymond HF, Li J, Yang H, Zhao J, Huan X, Stall R. Accessing HIV testing and treatment among men who have sex with men in China: a qualitative study. AIDS Care. 2014;26(3):372–8.

    Article  PubMed  Google Scholar 

  41. Wu Z, Zhao Y, Ge X, Mao Y, Tang Z, Shi CX, Chen C, Li Y, Qiu X, Nong G. Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention. PLoS Med. 2015;12(9):e1001874.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Tang H, Mao Y, Shi CX, Han J, Wang L, Xu J, Qin Q, Detels R, Wu Z. Baseline CD4 Cell Counts of Newly Diagnosed HIV Cases in China: 2006–2012. PLoS One. 2014;9(6):e96098.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Davis A, Best J, Luo J, Van Der Pol B, Dodge B, Meyerson B, Aalsma M, Wei C, Tucker JD: Risk behaviours, HIV/STI testing and HIV/STI prevalence between men who have sex with men and men who have sex with both men and women in China. Int J STD AIDS 2015: 0956462415596302

  44. Zhou W, Zhao M, Wang X, Schilling RF, Zhou S, Qiu H-Y, Xie N-H, Liu M-Q, Dong H-S, Yao Z-Z. Treatment Adherence and Health Outcomes in MSM with HIV/AIDS: Patients Enrolled in “One-Stop” and Standard Care Clinics in Wuhan China. PLoS One. 2014;9(12):e113736.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516–24.

    Article  PubMed  Google Scholar 

  46. Muessig KE, McLaughlin MM, Nie JM, Cai W, Zheng H, Yang L, Tucker JD. Suboptimal antiretroviral therapy adherence among HIV-infected adults in Guangzhou, China. AIDS Care. 2014;26(8):988–95.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Tang W, Best J, Zhang Y, Liu FY, Tso LS, Huang S, Yang B, Wei C, Tucker JD: Gay mobile apps and the evolving virtual risk environment: a cross-sectional online survey among men who have sex with men in China. Sex Transm Infect 2016

  48. Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis. 2011;52 suppl 2:S214–22.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Tang W, Best J, Zhang Y, Liu F, Tso LS, Huang S, Yang B, Wei C, Tucker JD. Gay Mobile Apps as an Emerging Virtual Risk Environment: A Cross-Sectional Online Survey among Men who have Sex with Men in China. Vancover: IAS; 2015.

    Google Scholar 

  50. Zheng L, Zheng Y. Efficacy of human immunodeficiency virus prevention interventions among men who have sex with men in China: a meta-analysis. Sex Transm Dis. 2012;39(11):886–93.

    Article  PubMed  Google Scholar 

  51. China_Food_and_Drug_Adminstration: Database of approved Active Pharmaceutical Ingredients (APIs) and API manufacturers in China. In Beijing; 2015.

  52. Tang W, Han L, Best J, Zhang Y, Mollan K, Kim J, Liu F, Hudgens M, Bayus B, Terris-Prestholt F, et al. Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China. Clin Infect Dis. 2016;62(11):1436–42.

    Article  PubMed  Google Scholar 

  53. Wang X, Wu Z, Tang Z, Nong Q, Li Y. Promoting HIV testing with home self-test kit among men who have sex with men in China: a feasibility study. Lancet. 2015;386:S68.

    Article  Google Scholar 

  54. Zhou Y, Li D, Lu D, Ruan Y, Qi X, Gao G. Prevalence of HIV and syphilis infection among men who have sex with men in China: a meta-analysis. Biomed Res Int. 2014;2014:620431.

    PubMed  PubMed Central  Google Scholar 

  55. Yan H, Zhang R, Wei C, Li J, Xu J, Yang H, McFarland W. A peer-led, community-based rapid HIV testing intervention among untested men who have sex with men in China: an operational model for expansion of HIV testing and linkage to care. Sex Transm Infect. 2014;90(5):388–93.

    Article  PubMed  Google Scholar 

  56. WHO: Consolidated Guidelines on HIV Testing Services. In. Geneva; 2015.

  57. Zhong F, Tang W, Cheng W, Lin P, Wu Q, Cai Y, Tang S, Fan L, Zhao Y, Chen X et al.: Acceptability and Feasibility of a Social-Entrepreneurship Model to Promote HIV Self-testing and linkage to care among MSM. HIV Med 2016, Accepted, in press.

  58. Cheng W, Cai Y, Tang W, Zhong F, Meng G, Gu J, Hao C, Han Z, Li J, Das A, et al. Providing HIV-related services in China for men who have sex with men. Bull World Health Organ. 2016;94(3):222–7.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Avery M, Meng G, Mills S. Two internet-based approaches to promoting HIV counselling and testing for MSM in China. Digit Cult Educ. 2014;6:216–29.

    Google Scholar 

  60. A New HIV/AIDS Intervention Model for MSM: Experience of Using Social Media for AIDS Interventions and HIV Testing Mobilization in China. China-Gates Foundation HIVPrevention Cooperation Program. September 2013. Accessed 7 Oct 2016.

  61. Tso LS, Tang W, Li H, Yan HY, Tucker JD. Social media interventions to prevent HIV: a review of interventions and methodological considerations. Curr Opin Psychol. 2016;9:6–10.

    Article  PubMed  Google Scholar 

  62. Guo B, Yu Z, Zhou X, Zhang D: From participatory sensing to mobile crowd sensing. In: Pervasive Computing and Communications Workshops (PERCOM Workshops), 2014 IEEE International Conference on: 2014: IEEE; 2014: 593–598.

  63. Tang W, Mao J, Liu C, Mollan K, Li H, Wong T, Zhang Y, Tang S, Hudgens M, Qin Y, et al. Reimagining Health Communication: A Non-Inferiority Randomized Controlled Trial of Crowdsourcing in China. Durban: International AIDS Society; 2016.

    Google Scholar 

  64. WHO: Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV. In. Geneva; 2012. Accessed 17 Oct 2016.

  65. Jackson T, Huang A, Chen H, Gao X, Zhong X, Zhang Y. Cognitive, psychosocial, and sociodemographic predictors of willingness to use HIV pre-exposure prophylaxis among Chinese men who have sex with men. AIDS Behav. 2012;16(7):1853–61.

    Article  PubMed  Google Scholar 

  66. Mijiti P, Yahepu D, Zhong X, Sun Y, Zhao T, Zhao Z, Abuduaili Z, Zhou H, Meng F, Dai J. Awareness of and willingness to use oral pre-exposure prophylaxis for HIV prevention among HIV-serodiscordant heterosexual couples: a cross-sectional survey in Xinjiang, China. PLoS One. 2013;8(7):e67392.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Zhang Y, Peng B, She Y, Liang H, Peng H-B, Qian H-Z, Vermund SH, Zhong X-N, Huang A. Attitudes toward HIV pre-exposure prophylaxis among men who have sex with men in western China. AIDS Patient Care STDs. 2013;27(3):137–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS One. 2012;7(3):e32329.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Gao F, Zhong X, Peng B, Zhang Y, Liang H, Zou Y, Dai J, Liu Q, Song B, Huang W, et al. Pre-exposure prophylaxis for HIV high risk groups: analysis of clinical compliance. Acad J Second Mil Med Uni. 2012;33(11):1186–93.

    Google Scholar 

  70. Zhang Y, Zhong X, Peng B, Huang W, Huang A. Cohort retention and predictors in HIV pre exposure prophylaxis clinical trial among men who have sex with men. Acad J Third Mil Med Uni. 2013;35(22):3.

    Google Scholar 

  71. Tucker JD, Fenton KA, Peckham R, Peeling RW. Social entrepreneurship for sexual health (SESH): a new approach for enabling delivery of sexual health services among most-at-risk populations. PLoS Med. 2012;9(7):e1001266.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Taggart T, Grewe ME, Conserve DF, Gliwa C, Roman Isler M. Social Media and HIV: A Systematic Review of Uses of Social Media in HIV Communication. J Med Internet Res. 2015;17(11):e248.

  73. Tucker JD. Hepatitis Testing Innovation Contest. Barcelona: International Liver Congress-EASL; 2016.

    Google Scholar 

  74. McNairy ML, Howard AA, El-Sadr WM. Antiretroviral therapy for prevention of HIV and tuberculosis: a promising intervention but not a panacea. J Acquir Immune Defic Syndr. 2013;63:S200–7.

    Article  CAS  PubMed  Google Scholar 

  75. Peters DH, Tran NT, Adam T. Implementation Research in Health: A Practical Guide. Geneva: World Health Organization; 2013.

    Google Scholar 

  76. Zhang Y, Kim JA, Liu F, Tso LS, Tang W, Wei C, Bayus BL, Tucker JD. Creative Contributory Contests to Spur Innovation in Sexual Health: 2 Cases and a Guide for Implementation. Sex Transm Dis. 2015;42(11):625–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


Sincere thanks are given to Colin Shepard, MD, and Zhijun Li, MD from Division of Global HIV/AIDS in China, China office of U.S. Centers for Disease Control & Prevention (CDC); Dr. James Yang from UNDP and Mr. John Shen from Beijing LGBT center for their strong support during the data collection process. Thanks are also given to two excellent young scholars, Jessica Mao and Wei Zhang, for their contributions in process of literature collection and report editing. We also would like to thank the staff at Social Entrepreneurship for Sexual Health (SESH) Global, Danlan Gongyi (淡蓝公益), Lingnan Partner (岭南伙伴), Guangzhou CDC, and Guangdong Provincial Center for Skin Diseases and STI Control, who contributed to our work.


This work was supported by the WHO-China office; National Institutes of Health [National Institute of Allergy and Infectious Diseases 1R01AI114310 to JT]; and UNC-South China STD Research Training Centre [Fogarty International Centre 1D43TW009532 to JT].

Availability of data and materials

The dataset supporting the conclusions of this article is included within the article’s Additional file 1.

Authors’ contributions

All authors have read and approved the final manuscript. This scoping review was prepared by Drs. Songyuan Tang, Weiming Tang, Kathrine Meyers, and Joseph Tucker. Drs. Polin Chan made significant contribution in process of literature collection. Drs. Polin Chan, and Zhongdan Chen reviewed the manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Joseph D. Tucker.

Additional information

Songyuan Tang and Weiming Tang are co-first authors.

Additional file

Additional file 1:

Annex: Summary of ongoing and completed interventions focus on the HIV care continuum among MSM in China (DOCX 137 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, S., Tang, W., Meyers, K. et al. HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review. BMC Infect Dis 16, 588 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: